A consortium of Warburg Pincus and ChrysCapital will compete with TPG, Blackstone and EQT, as well as Mankind Pharma, to acquire BSV Group, formerly Bharat Serum & Vaccines Ltd, valuing it at Rs 12,000-13,000 crore...
Brazil’s Dasa, Amil in advanced talks to combine hospital businesses
Brazil’s Diagnosticos da America (Dasa) and health insurance operator Amil are in advanced talks to combine their hospital businesses, Dasa said in a securities filing on Monday. Under the current negotiations...
Mankind Pharma in race with PEs to buy BSV Group at possible valuation of Rs 13,000 crore
A consortium of Warburg Pincus and ChrysCapital will compete with TPG, Blackstone and EQT, as well as Mankind Pharma, to acquire BSV Group, formerly Bharat Serum & Vaccines Ltd, valuing it at Rs 12,000-13,000 crore...
FTC loses bid to block $320 million hospital merger in North Carolina
A U.S. judge in North Carolina has denied the U.S. Federal Trade Commission’s request to block Novant Health’s $320 million acquisition of two hospitals in the state, a deal the agency said would lead to higher prices...
Merck to buy eye-focused drug developer EyeBio for as much as $3 bln
Merck on Wednesday agreed to buy privately held biotech EyeBio for as much as $3 billion, as it looks to diversify its portfolio of experimental drugs with treatments for eye diseases. The drugmaker agreed to pay $1.3...
Merck nears $1.3 bln cash deal for eye-drug company EyeBio, WSJ reports
Merck & Co is nearing a $1.3 billion cash deal to buy ophthalmology biotechnology company Eyebiotech in an agreement that could see an additional $1.7 billion in milestone payments, the Wall Street Journal reported...
KKR invests in Healthcare Revenue Solutions provider Infinx
Global PE fund KKR has announced its acquisition of a significant minority stake in Infinx Services, the leading healthcare revenue cycle solutions provider. Through this investment, KKR will leverage its extensive...
KKR in talks to buy into healthcare BPO company Infinx
KKR is looking to acquire a minority stake in the Tandon Group-owned healthcare BPO Infinx Healthcare. The global private equity major is likely to invest about $150 million, or Rs 1,250 crore, to acquire about 26%...
GSK intends to sell its remaining stake in Haleon
British drugmaker GSK said it plans to sell about 385 million shares, representing its entire shareholding, in spun-off consumer healthcare business Haleon. The latest offload will mark the fourth set of disposal GSK...
ChrysCapital invests $100 million in eyecare chain Centre for Sight
Homegrown private equity firm ChrysCapital is set to invest up to $100 million in New Delhi-based Centre for Sight for a “significant” minority stake, in a deal that will value the eyecare chain at $350-400...
J&J to exit spinoff Kenvue with latest stake sale
Tylenol maker Kenvue said on Monday that Johnson & Johnson will sell its remaining 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer health business. Based on...
Birla unit acquires ARMC IVF Fertility Centre to foray into South Indian market
Birla Fertility & IVF, a part of C K Birla Group, on Wednesday said it has forayed into the South Indian market with the acquisition of ARMC IVF Fertility Centre for an undisclosed amount. Currently, Birla Fertility...
